The presence of the Rb c-box peptide in the cytoplasm inhibits p210(bcr-abl) transforming function

Oncogene

Volumn 18, Issue 8, 1999, Pages 1589-1595

  Guo, Xiang Yang D ^a   Balague, Cristina ^b   Wang, Tao ^a   Randhawa, Gurvaneet ^c   Yuan, Zhimin ^f   Bachier, Carlos ^e   Greenberger, Joel ^d   Arlinghaus, Ralph ^e   Kufe, Donald ^f   Deisseroth, Albert B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

CML; Kinases; Leukemia; Oncogenes; Suppressor genes

Indexed keywords

BCR ABL PROTEIN; COMPLEMENTARY DNA; CYTOPLASM PROTEIN; INTERLEUKIN 3; ONCOPROTEIN; PLASMID VECTOR; PROTEIN TYROSINE KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033602093     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202479     Document Type: Article

References (24)

1. Ben-Neriah Y, Daley GO, Mes-Masson AM, Witte ON and Baltimore D. (1986). Science, 233, 212-214.
2. Daley GQ, Van Etten RA and Baltimore D. (1993). Science, 247, 824-830.
3. Gale RP and Canaani E. (1984). Proc. Natl. Acad. Sci. USA, 81, 5648-5652.
4. Goga A, McLaughlin J, Pendergast AM, Parmar K, Muller A, Rosenberg N and Witte ON. (1993). Mol. Cell. Biol., 13, 4967-4975.
5. Gossen M and Bujard H. (1992). Proc. Natl. Acad. Sci. USA, 89, 5547-5551.
6. Heisterkamp N, Stam K, Groffin J, De Klein A and Grosveld G. (1985). Nature, 315, 758-761.
7. Henderson YC, Guo XYD, Greenberger J and Deisseroth AB. (1997). Clin. Cancer Res., 3, 145-149.
8. Jain SK, Langdon WY and Varticovski L. (1997). Oncogene, 14, 2217-2228.
9. Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, Weichselbaum RR and Kufe DW. (1995). Nature, 376, 785-788.
10. Kipreos ET and Wang JYJ. (1992). Science, 256, 382-385.
11. Lugo TG, Pandergast AM and Witte ON. (1990). Science, 247, 1079-1082.
12. Muller AJ, Young JC, Pandergast AM, Pondel M, Landau NR, Littman DR and Witte ON. (1991). Mol. Cell. Biol., 11, 1785-1792.
13. Raitano AB, Hallpern JR, Hambuch TM and Sawyers CL. (1995). Proc. Nat. Acad. Sci. USA, 92, 11746-11750.
14. Rosenberg N and Witte ON. (1988). Adv. Virus Res., 35, 39-81.
15. Rowley JD. (1973). Nature, 243, 290-293.
16. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarrski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN and Calabretta B. (1997). EMBO J., 16, 6151-6161.
17. Skorski T, Palanisamy K, Nieborowska-Skorska ML, Ratajczak MZ, Wen SC, Zon G, Gerwirtz AM, Perussia B and Calabretta B. (1995). Blood, 86, 726-736.
18. Szczylik C, Skorski T, Nicolaides NC, Manzella L, Malaguarnera L, Venturelli D, Gewirtz AM and Calabretta B. (1991). Science, 253, 562-565.
19. Van Etten RA, Jackson P and Baltimore D. (1989). Cell, 58, 669-678.
20. Wang JYJ. (1988). Oncogene Res., 3, 293-298.
21. Welch PJ and Wang JYJ. (1993). Cell, 75, 779-790.
22. Yuan AM, Huang YY, Whang Y, Sawyers C, Weichselbaum R, Kharbanda S and Kufe D. (1996). Nature, 382, 272-274.
23. Zacksenhaus E, Bremner R, Phillips RA and Gallie BL. (1993). Mol. Cell Biol., 13, 4588-4599.
24. Zhang W, Guo XY and Deisseroth AB. (1994). Oncogene, 9, 2513-2521.